South Carolina further reduces penalty against manufacturer in drug marketing case
South Carolina's highest court has further reduced the penalty against a Johnson & Johnson subsidiary accused of deceptive drug marketing.
Group charged with transforming the Medicaid system says providers should be paid for quality
The group formed by Gov. Gina Raimondo to transform the Medicaid system recommended paying health care providers for the quality of their services in its final report, which was released Wednesday.
Humana, Weight Watchers, Allergan, Catabasis Pharmaceuticals are big market movers
Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE Humana Inc. (HUM), up $1.46 to $188.96 The health insurer provided a lower-than-expected second-quarter profit outlook as it moves ahead with its buyout of Aetna Inc.
MBIA, AMAG, Sysco, Vitae and National Bank of Greece are big market movers
Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE MBIA Inc., down $1.95 to $6.37 The financial guarantee insurance company's shares fell as Puerto Rico's governor warns that the island can't pay its $72 billion public debt.
Lennar, Box, Monsanto, Netflix and Freeport-McMoRan are big market movers
Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE Lennar Corp., up $2.06 cents to $51.06 The homebuilder reported better-than-expected fiscal second-quarter profit and revenue on a boost in home sales and prices.
Bristol-Myers Squibb to expand in academic-rich research centers in Cambridge, San Francisco
Bristol-Myers Squibb Co. will expand its presence in research centers in Cambridge, Massachusetts, and San Francisco, as it cuts jobs in Connecticut, the biopharmaceutical company announced Thursday.
Orthopedic device makers Zimmer and Biomet say they completed $13.35B cash and stock deal
Orthopedic device makers Zimmer Holdings and Biomet say they've completed their $13.35 billion cash-and-stock combination.
Samsung heir apologizes in public for MERS spread from Samsung hospital
The heir of the Samsung business group made a deep bow in apology as criticism mounts on a Samsung hospital for its role in spreading the Middle East respiratory syndrome.
Federal auditors expand review of Chippewa Cree tribe's mismanagement of disaster aid
U.S. government auditors are expanding their review of federal disaster aid mismanagement by the Chippewa Cree Tribe after finding fraud, waste and abuse in a project to demolish the Montana tribe's health clinic that was destroyed by flooding in 2010.
Teva completes buy of 4.6 percent stake in Mylan as part of $40 billion takeover attempt
Israeli drugmaker Teva Pharmaceutical said Friday that it completed buying 4.6 percent of Mylan N.V.
Too tough to lose weight?
New obesity study
Sugary drinks lead to 184K deaths every year
Sugary drinks kill
Teen dies from rare strain of plague
Plague kills healthy teen
Allegations of $712M in bogus Medicare billings
Cracking down on Medicare fraud
Tech entrepreneur: We’re not investing enough in life experiences
From rich to freeloader
Maine hospital and nursing union extend contract through July 2; negotiations resume June 24
Representatives for a Maine hospital say bargaining teams and a nursing union are agreeing to extend the nurses' current contract through July 2.
Big shareholder Abbott Laboratories backs Mylan's plan to remain independent, buy Perrigo
Mylan's biggest shareholder is backing the generic drugmaker's plan to remain a stand-alone company as it fights a takeover bid from larger rival Teva Pharmaceutical.
Tony Little: You can’t out-train a good diet
The business of fitness
Genetic testing not reliable?
Gene test flaws
Abbvie specifies breakdown of $21 billion cash-and-stock buyout of Pharmacyclics
Abbvie Inc. specified the stock and cash breakdown on Thursday of its previously announced $21 billion buyout of Pharmacyclics Inc.